Multicenter Study for Diagnosis and Treatment of Perianal Abscesses

Sponsor
University Hospital, Umeå (Other)
Overall Status
Recruiting
CT.gov ID
NCT02306382
Collaborator
(none)
200
1
2
168
1.2

Study Details

Study Description

Brief Summary

Drainage of perianal abscesses is a well established treatment. Traditionally its been done in general anesthesia after the swelling has been localised its been drained with a knife. After surgical intervention complications can occur with recidivism, chronic fistulas that go from the anal to the skin and sometimes the anal sphincter is damaged which can cause problems with incontinence.

Through ultrasound the abscess is opened under more controlled forms with a better visual overview. This is a new technique that has not been tested in larger studies. The aim with ultrasound-drainage as with traditional incision to drain the abscess so that the infected area can heal.

The hypothesis is a reduction of recurrences and formation of fistulas with the use of 3D ultrasonography.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Perianal abscess drainage
  • Device: 3D ultrasonography
N/A

Detailed Description

The individual patient is informed about the condition and if meets criteria is offered to take part in the study. Written information and informed consent always noted. Questions about the patients general medical condition is noted and if the person has had problems with perianal abscesses before.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized Controlled Multicenter Study for Diagnosis and Treatment of Perianal Abscesses.
Study Start Date :
Dec 1, 2012
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: ultrasonography, abscess

The experimental group will be treated after examination with 3D ultrasonography. Follow up after two months and one year.

Procedure: Perianal abscess drainage
The patientens will be randomly selected and after they have taken part and said yes to the study, half the group will undergo examination with ultrasound and half without. After this random selection all the patients abscess will be drained.
Other Names:
  • 1
  • Device: 3D ultrasonography
    The patientens will be randomly selected and after they have taken part and said yes to the study, half the group will undergo examination with ultrasound and half without. After this random selection all the patients abscess will be drained.
    Other Names:
  • 2
  • Other: Control group with clincial inscision

    The control group will have drainage of their perianal abscess in the OR without ultrasound. Follow-up after two months and one year.

    Procedure: Perianal abscess drainage
    The patientens will be randomly selected and after they have taken part and said yes to the study, half the group will undergo examination with ultrasound and half without. After this random selection all the patients abscess will be drained.
    Other Names:
  • 1
  • Outcome Measures

    Primary Outcome Measures

    1. adverse events [up to one year]

      Patients will be assessed in the outpatient clinic after 2 months and 1 year after surgical treatment. Eventual complications may include anal sepsis, recurrence of anal abscess and fistula formation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • perianal abscess that needs surgical treatment, over the age of 18
    Exclusion Criteria:
    • Under the age of 18 or unable to understand study information because of language difficulties or dementia.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Surgery Umea County Of Vasterbotten § Sweden 901 85

    Sponsors and Collaborators

    • University Hospital, Umeå

    Investigators

    • Principal Investigator: Karin Gustafsson, MD, University Hospital, Umeå
    • Study Director: Karin Strigård Strigård, MD, University Hospital, Umeå
    • Study Chair: Ulf Gunnarsson, MD, University Hospital, Umeå

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Karin Gustafsson, MD, University Hospital, Umeå
    ClinicalTrials.gov Identifier:
    NCT02306382
    Other Study ID Numbers:
    • 1-Gustafsson
    First Posted:
    Dec 3, 2014
    Last Update Posted:
    May 18, 2022
    Last Verified:
    May 1, 2022
    Keywords provided by Karin Gustafsson, MD, University Hospital, Umeå
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 18, 2022